Literature DB >> 27124481

Phenotypical characterization of regulatory T cells in humans and rodents.

A L Rodríguez-Perea1, E D Arcia1, C M Rueda2, P A Velilla1.   

Abstract

Regulatory T cells (Tregs ) constitute a fascinating subpopulation of CD4(+) T cells due to their ability to limit the immune response against self and non-self antigens. Murine models and antibodies directed against surface and intracellular molecules have allowed elucidation of the mechanisms that govern their development and function. However, these markers used to their classification lack of specificity, as they can be expressed by activated T cells. Similarly, there are slight differences between animal models, in steady state and pathological conditions, anatomical localization and strategy of analysis by flow cytometry. Here, we revised the most common markers utilized for Treg typification by flow cytometry such as CD25, forkhead box protein 3 (FoxP3) and CD127, along with our data obtained in different body compartments of humans, mice and rats. Furthermore, we revised and determined the expression of other molecules important for the phenotypical characterization of Treg cells. We draw attention to the drawbacks of those markers used in chronic states of inflammation. However, until a specific marker for the identification of Tregs is discovered, the best combination of markers will depend upon the tissue or the degree of inflammation from which Tregs derive.
© 2016 British Society for Immunology.

Entities:  

Keywords:  human; regulatory T cells; rodent; spleen and lymph nodes

Mesh:

Substances:

Year:  2016        PMID: 27124481      PMCID: PMC4991523          DOI: 10.1111/cei.12804

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  105 in total

1.  A subpopulation of CD103(pos) ICOS(pos) Treg cells occurs at high frequency in lymphopenic mice and represents a lymph node specific differentiation stage.

Authors:  Thomas Barthlott; Angela J T Bosch; Caroline Berkemeier; Rubén Nogales-Cadenas; Lukas T Jeker; Marcel P Keller; Alberto Pascual-Montano; Georg A Holländer
Journal:  Eur J Immunol       Date:  2015-04-17       Impact factor: 5.532

2.  CD4+CD25high regulatory cells in human peripheral blood.

Authors:  C Baecher-Allan; J A Brown; G J Freeman; D A Hafler
Journal:  J Immunol       Date:  2001-08-01       Impact factor: 5.422

3.  Differential expression of interleukin-2 and gamma interferon in human immunodeficiency virus disease.

Authors:  S F Sieg; D A Bazdar; C V Harding; M M Lederman
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

4.  Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cells.

Authors:  W F Ng; P J Duggan; F Ponchel; G Matarese; G Lombardi; A D Edwards; J D Isaacs; R I Lechler
Journal:  Blood       Date:  2001-11-01       Impact factor: 22.113

5.  Foxp3+ CD4 regulatory T cells limit pulmonary immunopathology by modulating the CD8 T cell response during respiratory syncytial virus infection.

Authors:  Ross B Fulton; David K Meyerholz; Steven M Varga
Journal:  J Immunol       Date:  2010-07-16       Impact factor: 5.422

6.  Control of autoimmune myocarditis and multiorgan inflammation by glucocorticoid-induced TNF receptor family-related protein(high), Foxp3-expressing CD25+ and CD25- regulatory T cells.

Authors:  Masahiro Ono; Jun Shimizu; Yoshiki Miyachi; Shimon Sakaguchi
Journal:  J Immunol       Date:  2006-04-15       Impact factor: 5.422

7.  The effect of high-mobility group box 1 protein on activity of regulatory T cells after thermal injury in rats.

Authors:  Li-Feng Huang; Yong-Ming Yao; Li-Tian Zhang; Ning Dong; Yan Yu; Zhi-Yong Sheng
Journal:  Shock       Date:  2009-03       Impact factor: 3.454

8.  Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production.

Authors:  Sarah E Allan; Sarah Q Crome; Natasha K Crellin; Laura Passerini; Theodore S Steiner; Rosa Bacchetta; Maria G Roncarolo; Megan K Levings
Journal:  Int Immunol       Date:  2007-02-27       Impact factor: 4.823

9.  Developmental stage, phenotype, and migration distinguish naive- and effector/memory-like CD4+ regulatory T cells.

Authors:  Jochen Huehn; Kerstin Siegmund; Joachim C U Lehmann; Christiane Siewert; Uta Haubold; Markus Feuerer; Gudrun F Debes; Joerg Lauber; Oliver Frey; Grzegorz K Przybylski; Uwe Niesner; Maurus de la Rosa; Christian A Schmidt; Rolf Bräuer; Jan Buer; Alexander Scheffold; Alf Hamann
Journal:  J Exp Med       Date:  2004-02-02       Impact factor: 14.307

10.  Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression.

Authors:  Tobias Bopp; Christian Becker; Matthias Klein; Stefan Klein-Hessling; Alois Palmetshofer; Edgar Serfling; Valeska Heib; Marc Becker; Jan Kubach; Steffen Schmitt; Sabine Stoll; Hansjörg Schild; Martin S Staege; Michael Stassen; Helmut Jonuleit; Edgar Schmitt
Journal:  J Exp Med       Date:  2007-05-14       Impact factor: 14.307

View more
  65 in total

1.  CD4+CD25+ regulatory T-cells: a potential target for treating patients with chronic HBV infection.

Authors:  Jiezuan Yang; Lanjuan Li
Journal:  Cell Mol Immunol       Date:  2017-08-07       Impact factor: 11.530

Review 2.  Recent advances in CD8+ regulatory T cell research.

Authors:  Yating Yu; Xinbo Ma; Rufei Gong; Jianmeng Zhu; Lihua Wei; Jinguang Yao
Journal:  Oncol Lett       Date:  2018-03-29       Impact factor: 2.967

Review 3.  The role of FOXP3+ regulatory T cells in human autoimmune and inflammatory diseases.

Authors:  A Mohr; M Atif; R Balderas; G Gorochov; M Miyara
Journal:  Clin Exp Immunol       Date:  2019-03-24       Impact factor: 4.330

4.  Increased circulating regulatory T cells in medicated people with schizophrenia.

Authors:  Deanna L Kelly; Xin Li; Catherine Kilday; Stephanie Feldman; Sarah Clark; Fang Liu; Robert W Buchanan; Leonardo H Tonelli
Journal:  Psychiatry Res       Date:  2018-09-05       Impact factor: 3.222

5.  The induction of autoimmune hepatitis in the human leucocyte antigen-DR4 non-obese diabetic mice autoimmune hepatitis mouse model.

Authors:  M Yuksel; X Xiao; N Tai; Manakkat Vijay; E Gülden; K Beland; P Lapierre; F Alvarez; Z Hu; I Colle; Y Ma; L Wen
Journal:  Clin Exp Immunol       Date:  2016-08-23       Impact factor: 4.330

Review 6.  Helicobacter pylori Deregulates T and B Cell Signaling to Trigger Immune Evasion.

Authors:  Victor E Reyes; Alex G Peniche
Journal:  Curr Top Microbiol Immunol       Date:  2019       Impact factor: 4.291

7.  High proportions of PD-1+ and PD-L1+ leukocytes in classical Hodgkin lymphoma microenvironment are associated with inferior outcome.

Authors:  Peter Hollander; Peter Kamper; Karin Ekstrom Smedby; Gunilla Enblad; Maja Ludvigsen; Julie Mortensen; Rose-Marie Amini; Stephen Hamilton-Dutoit; Francesco d'Amore; Daniel Molin; Ingrid Glimelius
Journal:  Blood Adv       Date:  2017-08-08

8.  Identification and Purification of Human Memory T Helper Cells from Peripheral Blood.

Authors:  Alessia Capone; Elisabetta Volpe
Journal:  Methods Mol Biol       Date:  2021

Review 9.  Targeting regulatory T cells for improving cancer therapy: Challenges and prospects.

Authors:  Bilikere S Dwarakanath; Abdullah Farooque; Seema Gupta
Journal:  Cancer Rep (Hoboken)       Date:  2018-05-15

10.  Investigation of immune cell markers in feline oral squamous cell carcinoma.

Authors:  Ellen E Sparger; Brian G Murphy; Farina Mustaffa Kamal; Boaz Arzi; Diane Naydan; Chrisoula T Skouritakis; Darren P Cox; Katherine Skorupski
Journal:  Vet Immunol Immunopathol       Date:  2018-06-13       Impact factor: 2.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.